268 results
8-K
EX-10.1
ALNY
Alnylam Pharmaceuticals Inc
4 Mar 24
Departure of Directors or Certain Officers
4:33pm
provided below and return it to me so that your separation benefits can begin. Please note that, in order to be effective, you cannot sign this Letter … ) as of the Separation Date, less lawful deductions.
2. After the Separation Date, except as provided below, you will not be entitled to receive any benefits paid
8-K
EX-99.1
6a00azj87wtdp
10 Oct 23
Alnylam Announces Receipt of Complete Response Letter from U.S. FDA for Supplemental New Drug Application for Patisiran for the Treatment of the
7:30am
8-K
EX-10.1
0y8 55fpro9hqc
3 Aug 23
Alnylam Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Period Activity
8:10am
8-K
bmvpy6
3 Aug 23
Alnylam Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Period Activity
8:10am
8-K
EX-99.1
vje3xrfp6
26 Jul 23
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-4.1
sddv09 68
16 Sep 22
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-99.1
a4pemi79i
14 Jun 22
Other Events
7:30am